Research funding and patent outcomes in Malaysian Research Universities: An outcome-based accountability assessment

Public research funding is expected to strengthen university innovation, but observed patent events cannot be treated as same-year products of annual allocations. This article assesses the alignment of Malaysian Research University (MRU) funding, patent outputs, and downstream commercialisation measures within an Outcome-Based Budgeting (OBB) framework. It combines qualitative document analysis of a 24-source corpus with descriptive ratios calculated from a non-public MyRA II administrative extract and the official MyIPO historical patent table. MRU patent filings fell from 343 in 2015 to 144 in 2020 (58.0%), while MyIPO’s separately defined ‘Malaysia’ applications fell from 1375 to 1110 (19.3%). For 2016-2022, the aggregate funding-to-observed-filing ratio ranged from RM0.56 million to RM0.87 million. These descriptive ratios do not measure causal efficiency, and annual patent grants are especially unsuitable for same-year attribution because examination introduces multi-year lags. The 2025 Federal Expenditure Estimates for the Ministry of Higher Education include publication and self-generated-income indicators, but the reviewed pages do not specify patent-quality, licensing, spin-off, or adoption indicators. The article’s contribution is a source-audited, non-causal diagnostic that integrates bureaucratic theory with OBB and proposes a mission-specific, lag-sensitive innovation scorecard. Limitations include aggregate administrative data, non-equivalent MRU and MyIPO definitions, and single-coder document analysis.